Correction to: Pharm Res (2018) 35: 64
The third author’s name was mistakenly published with an umlaut (Isabelle Köhler). The correct spelling is “Isabelle Kohler”.
The listing for Reference 195 is incorrect. The correct listing is: van den Brink WJ, Wong YC, Gülave B, van der Graaf PH, de Lange ECM. Revealing the neuroendocrine response after remoxipride treatment using multi-biomarker discovery and quantifying it by PK/PD modeling. AAPS J [Internet]; 2017;19(1):274–285. Available from: http://link.springer.com/10.1208/s12248-016-0002-3
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s11095-017-2333-x
Rights and permissions
About this article
Cite this article
van den Brink, W.J., Palic, S., Kohler, I. et al. Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments. Pharm Res 35, 102 (2018). https://doi.org/10.1007/s11095-018-2388-3
Published:
DOI: https://doi.org/10.1007/s11095-018-2388-3